Detecting amyloid-β pathology in subjective cognitive decline using plasma and CSF biomarkers
{{output}}
Background: Subjective cognitive decline (SCD) may represent an early stage of Alzheimer's disease (AD), but biomarker studies in this population are limited. Therefore, we compared the performance of a comprehensive panel of no... ...
